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EFFECTS OF RACE, SOCIOECONOMIC FACTORS ON EMERGENCY
MANAGEMENT OF THREATENED AND EARLY PREGNANCY LOSS
Connie Cheng, Steven L. Bernstein, Linda Fan, and Leigh Evans. Department of
Emergency Medicine, Yale University, School of Medicine, New Haven, CT.
Our study aims to determine the effects of race, insurance, and hospital
characteristics on the management of threatened abortion and early pregnancy loss.
In this retrospective cohort study using the National Hospital Ambulatory Medical
Care Survey, patient record files from 2002-2010 with diagnoses of threatened
abortion, hemorrhage in pregnancy, or incomplete, inevitable, or unspecified
spontaneous abortion were examined using logistic regression. Primary outcomes
were rates of admission and active management, defined as surgical termination or
use of abortifacients misoprostol or Cytotec. Covariates included race/ethnicity, age,
insurance, and hospital location, ownership, and metropolitan status. Of 5,882,623
ED visits for threatened abortion and early pregnancy loss, 15% were admitted and
1.3% were actively managed. Compared to white women, black women were 0.83
times as likely to be admitted (95% CI 0.83-0.84), but 4.37 times as likely be actively
managed (95% CI 4.25-4.50). Admission was more likely for “Other” women (Asian,
Native Hawaiian, Native Alaskan, Native American, mixed race; OR 2.14, 95% CI
2.11-2.17), Medicaid/SCHIP (OR 1.24, 95% CI 1.22-1.25) and Self-pay (OR 1.04,
95% 1.03-1.05) compared to reference groups of white and privately insured women.
Historically-marginalized groups, including uninsured, black, and “Other” women,
were more likely to be actively managed. Exceptions were Latina (OR 0.84, 95% CI
0.80-0.89) and Medicaid/SCHIP-insured women (OR 0.13, 95% CI 0.12-0.15).
Nonwhite women were less likely to be treated for pain, especially Latinas (OR 0.29,
95% CI 0.28-0.29). The etiology of these disparities is complex, but providers may
seek to better understand their own preconceptions of patient risk, and to strengthen
social support, communication, and shared decision-making.
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Introduction
The most common abnormal finding in a woman with a positive pregnancy
test and vaginal bleeding is spontaneous abortion [1]. Approximately half of all
women who experience vaginal bleeding during pregnancy will miscarry [2], with
over twice the risk of spontaneous abortion when bleeding is moderate or heavy
[3]. Prior to twenty weeks of gestation, the presence of vaginal bleeding is called
threatened abortion. Spontaneous abortion is the non-induced expulsion of
products of conception from the uterus during the same gestational period [4].
Spontaneous abortion is categorized as “complete” when all products of
conception have been expelled from the uterus and the cervical os is closed [5].
Complete spontaneous abortion requires no further intervention, but
several more complicated variants of spontaneous abortion exist as well [6, 7].
Among these variants are “incomplete” spontaneous abortion, where products of
conception are passed with retention of some tissue; and “inevitable”
spontaneous abortion, which describes vaginal bleeding through an open cervix,
without delivery of pregnancy-related tissue [8]. To simplify the terminology of
spontaneous abortion, subtypes are sometimes categorized using a combination
of ultrasound appearance and clinical presentation. This scheme recognizes the
subtypes of “complete”, “incomplete”, and “delayed” spontaneous abortion [7].
Unlike incomplete abortion, delayed abortion includes anembryonic or missed
abortions. It occurs before tissue is passed and presents with minimal vaginal
bleeding [7].
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Diagnostic Work-Up
Diagnostic work-up is important in differentiating spontaneous abortion
from other outcomes of pregnancy. Patients with spontaneous abortion often
present with lower abdominal pain and vaginal bleeding, which are nonspecific
symptoms also found in ectopic pregnancy, molar pregnancy, or simply normal
gestation. For a definitive diagnosis, the American Congress of Obstetricians and
Gynecologists recommends serum β-hCG testing and ultrasonography to assess
for viability of intrauterine gestation [9]. Ultrasonography findings diagnostic of
early pregnancy loss include crown-rump length of 7mm without heartbeat, sac
diameter of 25mm with no embryo, scan showing gestational sac without yolk
sac and absence of embryo with heartbeat 2 weeks later, or scan showing
gestational sac with yolk sac and absence of embryo with heartbeat 11 days or
later [10]. Other diagnostic steps tests include type and screen and complete
blood count (CBC) [6, 9].

Treatment
For spontaneous abortion that is not complete, treatment modalities
include expectant management, surgery, or medication [11, 12]. All three
methods have been shown to treat spontaneous abortion safely, and rates of
serious complication are similarly low. Expectant management requires waiting
for spontaneous resolution, a possibly month-long process that can worsen
anxiety and grief in patients. This option should be limited to gestations up to
eight weeks, and it is not recommended for hemodynamically unstable patients
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[9]. In terms of surgical treatment, spontaneous abortion can be managed using
sharp curettage or suction curettage, which uses either manual vacuum
aspiration (MVA) or electric vacuum aspiration (EVA) [13]. MVA and EVA can
also be performed in the outpatient setting, which has been shown to be
significantly more time- and cost-effective than performing the same procedure in
the operating room [14]. Complications of curettage, however, include uterine
perforation, intrauterine adhesions, cervical trauma, hemorrhage, as well as
infection in 0.1%–4.7% of patients [15]; patients may also face risks associated
with anesthesia. Lastly, medical treatment typically involves use of a synthetic
prostaglandin analogue, with or without an antiprogesterone [16, 17]. Misoprostol
is a commonly used prostaglandin E1 analogue that ripens the cervix and
induces uterine contractions, expelling products of conception and other tissue.
The typical regimen includes 800 mg vaginal misoprostol with a repeat dose in
three days [9], all of which can be administered in the outpatient setting.

Additionally, pain treatment is often included in the management of
spontaneous abortion. Abdominal cramping is common upon presentation as
well as after surgical intervention, prompting preemption with NSAID and
lidocaine through a paracervical block [18].

Epidemiology
An estimated 15–20% of clinically recognized pregnancies result in
spontaneous abortion [19]. This incidence, however, is derived from retrospective
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studies, which cannot account for “silent” losses: those unrecognized or mistaken
for delayed menses. Thus, the actual rate is thought to range from 25% to as
high as 71% [20, 21]. Some groups of women are particularly vulnerable to
spontaneous miscarriage and its complications. Women older than 35 years of
age, for instance, are more likely to experience spontaneous abortion as well as
associated mortality [22, 23]; other reproductive risk factors include chromosomal
abnormalities, alcohol use, cigarette smoking, and previous abortion history [6].
Importantly, differences by race have also been identified. Consistent with overall
pregnancy-related maternal [24] and fetal [25] mortality, black women may be
twice as likely to experience spontaneous abortion as white women [26], even
after adjusting for previous miscarriage. Nonwhite women overall may be four
times as likely to die from a spontaneous abortion [22].
These demographically-based differences in spontaneous abortion are
known to exist, and similar disparities are pervasive throughout other obstetrics
outcomes. However, the etiology of these disparities remains unclear. Currently
posited theories attribute disparate pregnancy outcomes to social risk factors,
such as decreased and delayed prenatal care among marginalized populations
[27, 28]. Indeed, black women tend to have lower health insurance coverage
[29], less prenatal care, and later initiation of care during pregnancy compared to
white women [30-32]. Medicaid-insured or uninsured women are also more likely
to delay seeking preventative care [33, 34]. These delays are especially relevant
in the context of spontaneous abortion, as the risk of associated maternal death
increases with gestational age: between trimesters (Relative Risk = 8 for death in
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second vs. first trimester) and even within trimesters (RR = 5.0 at 13-15 weeks,
compared to RR=12.9 at 16-20 weeks) [22].

Disparities within Other Obstetrics Outcomes
While the definition of “health disparity” varies across multiple institutions,
our research defines disparities using definitions from the World Health
Organization (WHO): “differences in health which are not only unnecessary and
avoidable but, in addition, are considered unfair and unjust [35]”, as well as from
the Agency for Healthcare Research and Quality (AHRQ), where disparities are
any statistically significant differences among populations are found, differing
from the reference group by at least 10 percent [36].
Demographically-based disparities are well known in terms of healthcare
access and care-seeking behaviors. They are also commonly cited as possible
perpetuators of racial and socioeconomic disparities in pregnancy outcomes.
Separately, demographically-based variations in obstetrics management have
also been identified, including racial disparities in C-section (CS) rates [37] and
racial, socioeconomic disparities in laparoscopic hysterectomy rates [38]. Fewer
studies, however, have investigated demographically-based variations in
management as possible effectors of disparate morbidity and mortality. One
study of 35,000 women diagnosed with ectopic pregnancy found that nonwhite
women were 10-18% less likely to receive laparoscopy as opposed to
laparotomy, compared to the reference group [27] – though laparoscopy is the
preferred, less invasive surgical approach over laparotomy [39-41]. The same
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study also found higher rates of complication, including hemoperitoneum,
transfusions, and longer hospitalization stays, among nonwhite and low- or uninsured women [27]. Associated mortality is also higher among African American
women, who may experience 6.8 times as many ectopic pregnancy fatalities as
white women for every 100,000 live births [42]. Of course, these findings cannot
demonstrate a causal relationship between disparate management and
outcomes. Moreover, the etiology of demographically-based differences in
outcome are likely multifactorial and complex. Nevertheless, differences in
management may logically contribute to disparity in outcomes.
To our knowledge, no similar studies have examined demographicallybased differences in management within spontaneous abortion. Whether or not
they exist, any differences in spontaneous abortion management would indeed
result in different outcomes, as varying success rates are demonstrated across
treatment modalities. In an assessment of missed or incomplete 1st trimester
miscarriages, a 2005 Cochrane meta-analysis of 27 studies (n=3,177) found
surgical management to be the most frequently successful method of achieving
complete evacuation (compared to medical management, risk difference (RD) =
32.8%, number needed to treat (NNT) = 3, p<0.001) [43]. A prospective study
found similar results, where treatment failed in more misoprostol-treated women
than surgically-managed women with early pregnancy failure [44]. However,
providers may consider that surgery can result in complications such as
intrauterine adhesions. Medical treatment has also been found to result in
complete evacuation more often than expectant management (RD = 49.7%, NNT
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= 2, p<0.001) [43]. A randomized controlled trial found that a single dose of 800
mg vaginal misoprostol resulted in complete expulsion for 71% of women within
three days. The completion rate increased to 84% after repeat dose [44]. Medical
treatment can often be administered at home. Subsequent evaluation using
ultrasound or serial β-hCG measurements may be used to confirm complete
expulsion [9]. Lastly, expectant management has the lowest success rates of all
three methods of intervention [43]. Nearly half of women receiving expectant
management eventually request surgery one week post-diagnosis. By two weeks
after diagnosis, as many as 70% of patients have been found to request surgery
[45]. Fewer complications are seen with expectant and medical treatment
compared to surgery, though a longer duration of vaginal bleeding may occur
after surgical intervention [11].
No absolute standard treatment algorithm exists for the treatment of
spontaneous abortion. Although this allows for a more personalized treatment
approach for each patient, it also introduces increased opportunity for biased,
subjective, or inconsistency in clinical decision-making. Additionally,
demographically-based disparities in management have been identified in other
pregnancy outcomes, such as ectopic pregnancy. Taken together, disparities in
the management of spontaneous abortion may conceivably exist as well.

Statement of Purpose
Here we identify demographically-based differences in the management of
incomplete and delayed spontaneous abortion, threatened abortion, and other
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hemorrhage in pregnancy. We hypothesize that nonwhite, uninsured or
Medicaid-insured, low-income women are more likely to be 1) discharged to
home and 2) managed expectantly, upon presenting to the emergency
department.

Materials and Methods
Study Design and Setting:
This study acknowledges the social construct of race and groups patients
based on categories assigned by the data source. The categories used by the
National Hospital Ambulatory Medical Care Survey (NHAMCS) included nonHispanic white (hereafter referred to as “white”), black, non-white Hispanic
(hereafter referred to as “Latina”), Asian, Native Hawaiian, Native Alaskan, or
American Indian (hereafter referred to as “Native American”). For statistical
analysis purposes, this study collapses Asian, Native Hawaiian, Native Alaskan,
and Native American race/ethnicity, collectively referenced as “Other” women of
color.
A retrospective cohort study was performed, using pooled data from the
NHAMCS from 2002-2010, inclusive. The NHAMCS is the largest national
emergency department (ED) database, administered annually by the Centers for
Disease Control and Prevention, National Center for Health Statistics, since
1992. Its findings are collected from a national sample of emergency and
outpatient departments in nonfederal, short-stay or general hospitals. This
analysis focuses on visits to hospital EDs, for which the probability design
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involves 112 geographic primary sampling units, approximately 480 hospitals
within these primary sampling units, and patient visits within the emergency
service areas. Sample hospitals are randomly assigned to 16 panels that rotate
across 13 4-week reporting periods throughout the year. The initial sample frame
of hospitals was based on the 1991 SMG hospital database, now maintained by
IMS Health.
Data Collection and Processing:
Hospitals are inducted into the NHAMCS by field representatives of the
U.S. Census Bureau. Hospital staff or Census Bureau field representatives
complete a patient record form for each sampled visit based on information
obtained from the medical record. The data collected include information on
patient demographics, vital signs, up to three diagnosis codes as listed by the
provider, diagnostic tests ordered, procedures provided, providers consulted, up
to eight medications prescribed, and disposition, including hospital discharge
information if admitted (since 2005). Between 2002-2010, approximately 91.2%
of sampled hospitals participated in the survey, and about 91.1% of sampled EDs
provided complete information on their sample visits for a total unweighted
response rate of 85.3%.
The NHAMCS is approved annually by the Ethics Review Board of NCHS
with waivers of requirements to obtain informed consent of patients and patient
authorization for release of patient medical record data by health care providers.
Data processing, including medical coding of reason for visit, cause of injury,
diagnosis, and medications are performed by SRA International, Inc., Durham,
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NC. As part of the quality assurance procedure, a 10% quality control sample of
patient record files is independently keyed and coded. Error rates typically range
between 0.3% and 0.9% for various survey items.
This study analyzes 9 years of data from 2002-2010, which includes
323,135 patient record files provided by EDs across the United States. Initial
analysis of demographic factors included all patient record files (PRFs) meeting
the following criteria: (1) any-listed provider or recoded provider diagnosis, or (2)
principal hospital discharge diagnosis with International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code indicating
threatened abortion (ICD-9-CM 640, 640.03), hemorrhage in pregnancy (640.8,
640.83, 640.9, 640.93), as well as incomplete or unspecified spontaneous
abortion with or without complications (634, 634.01, 634.1, 634.11, 634.2,
634.21, 634.3, 634.31, 634.4, 634.41, 634.5, 634.51, 634.6, 634.61, 634.7,
634.71, 634.8, 634.81, 634.9, 634.91, 637.01). When ICD-9 codes indicated
complete spontaneous abortion or delivered pregnancy, records were excluded.
After exclusion of complete spontaneous abortion, note that the remaining
variants of spontaneous abortion are referenced as “non-complete” spontaneous
abortion for simplicity. Duplicate records were also excluded to identify unique
admissions. Also excluded were records with no disposition listed, with a
disposition listed as “unknown”, those who left against medical advice, or those
who left before/after examination.
Records meeting these inclusion criteria were weighted by patient weight
(PATWT), as provided by the NHAMCS. They were then assessed for baseline
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demographic characteristics, diagnostic procedures performed, pain
management, hospital discharge diagnosis, disposition, and method of
management. Select diagnostic procedures were chosen for our study based on
ACOG standard-of-care recommendations, as well as availability of
documentation in the NHAMCS intake. To determine whether pain was treated,
records were included if any of the 8 listed medications was classified as (1)
anesthetic or adjunct to anesthetic (National Directory Drug Class 100, 117, 118,
119, 121, 1275), (2) analgesic (1275, 1720, 1721, 1722), (3) NSAID (1727), or
(4) relief of pain (1700). Note that prior to 2006, the FDA’s National Drug Code
Directory was used for therapeutic classification. Therefore, from 2002-2006,
therapeutic classifications reflect the primary drug class as described by the
National Drug Code Directory. Since 2006, Multum’s Lexicon Drug Database
[http://www.multum.com] has been used to classify medications. Thus, from
2006-2010, therapeutic classifications reflect Category 1 of Multum‘s 3-level
nested category system.
Primary outcomes were disposition and management. A disposition of
“admission” was designated if the patient record indicated any of the following
dispositions: Transfer to any hospital, Admission to any hospital, or Admission to
observation unit. A disposition of “discharge” was designated if the patient record
listed any of the following dispositions: No follow-up planned; Return if needed;
or Returned/referred to physician, nursing home, social services, or any other
program except a hospital. In terms of management approach, “actively treated”
patients included those receiving either medical management (receipt of
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misoprostol or Cytotec) or surgery (admission to the OR). For all other patients,
expectant management was assumed – regardless of admission or discharge.
Note that “admission to the OR” was documentable as a disposition option only
since 2005. Secondary outcomes included use of diagnostic tests and
procedures (pregnancy test, ultrasonography, and complete blood count), as well
as use of consulting physician, assumed to be an obstetrician / gynecologist.
An initial analysis was conducted describing baseline characteristics of the
study population and hospital characteristics. Subsequently, we used logistic
regression analysis to determine the effects of clinically relevant covariates on
primary and secondary outcomes. The weighted regression model incorporated
the following covariates: age, race/ethnicity, insurance provider, hospital
geographic region, hospital ownership, hospital metropolitan status, and an
interaction term consisting of the product of insurance by race. Simultaneous
data entry, or the enter method, was used in this regression approach. Statistical
analysis was performed using commercially available software (SPSS version
22.0, IBM Corporation, Armonk, NY). Exemption was granted by the Human
Investigations Committee at Yale New Haven Hospital.
All data, which is publicly available, was downloaded and analyzed by
Connie Cheng. Dr. Dziura, Mr. Cheng, and Mr. Jawitz were consulted for
guidance around statistical methods. Dr. Evans, Dr. Bernstein, and Dr. Fan
contributed their thoughts to the interpretation of results. Thesis was written by
Connie Cheng.
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Results
Using the NHAMCS database, 2,060 visits representing threatened
abortions and early pregnancy loss (excluding completed spontaneous abortions)
in the United States were identified during 9 years (2002–2010). Samples were
weighted by patient weight, reflecting 6,017,788 total cases. Exclusion criteria
were applied, resulting in a final cohort size of 5,882,623 threatened, incomplete,
delayed spontaneous abortion and other hemorrhage in pregnancy. Table 1
describes the ICD-9 codes used to identify these cases.

Table 1. ICD-9 Diagnoses designated as threatened abortion and early
pregnancy loss from NHAMCS record files
Spontaneous Abortion Unspecified Complicated By Genital
634
Tract And Pelvic Infection
Spontaneous Abortion Incomplete Complicated By Genital
634.01
Tract And Pelvic Infection
Spontaneous Abortion Unspecified Complicated By Delayed
634.1
Or Excessive Hemorrhage
Spontaneous Abortion Incomplete Complicated By Delayed
634.11
Or Excessive Hemorrhage
Spontaneous Abortion Unspecified Complicated By Damage
634.2
To Pelvic Organs Or Tissues
Spontaneous Abortion Incomplete Complicated By Damage
634.21
To Pelvic Organs Or Tissues
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Spontaneous Abortion Unspecified Complicated By Renal
634.3
Failure
Spontaneous Abortion Incomplete Complicated By Renal
634.31
Failure
Spontaneous Abortion Unspecified Complicated By
634.4
Metabolic Disorder
Spontaneous Abortion Incomplete Complicated By Metabolic
634.41
Disorder
634.5

Spontaneous Abortion Unspecified Complicated By Shock

634.51

Spontaneous Abortion Incomplete Complicated By Shock
Spontaneous Abortion Unspecified Complicated By

634.6
Embolism
634.61

Spontaneous Abortion Incomplete Complicated By Embolism
Spontaneous Abortion Unspecified With Other Specified

634.7
Complications
Spontaneous Abortion Incomplete With Other Specified
634.71
Complications
Spontaneous Abortion Unspecified With Unspecified
634.8
Complication
Spontaneous Abortion Incomplete With Unspecified
634.81
Complication
634.9

Spontaneous Abortion Unspecified Without Complication

634.91

Spontaneous Abortion Incomplete Without Complication
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Unspecified Abortion Incomplete Complicated By Genital
637.01
Tract And Pelvic Infection
640

Threatened Abortion Unspecified As To Episode Of Care

640.03

Threatened Abortion Antepartum
Other Specified Hemorrhage In Early Pregnancy Unspecified

640.8
As To Episode Of Care
640.83

Other Specified Hemorrhage In Early Pregnancy Antepartum
Unspecified Hemorrhage In Early Pregnancy Unspecified As

640.9
To Episode Of Care
640.93

Unspecified Hemorrhage In Early Pregnancy Antepartum

Baseline characteristics of the population, their dispositions, management,
and diagnostic procedures are given in Table 2. Most patients were
Medicaid/SCHIP-insured white women aged 25-44 years (mean age 26.5 years),
receiving treatment at a metropolitan, voluntary non-profit hospital center.
Women presenting with threatened and non-completed spontaneous abortion
were usually discharged home (5,274,533 patients, or 87.6% of cohort), while
about 608,090 threatened abortions (10.1%) resulted in hospital admission. In
terms of management, expectant management was the preferred approach,
occurring in 5,941,511 or 98.7% of patients. Medical or surgical treatment
occurred in only 1.3% cases, or 76,277 threatened and spontaneous abortions.
Diagnostic procedures included use of ultrasound, pregnancy test, complete
blood count (CBC), and use of consulting physician, which were assumed to be
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OB/GYNs. The most common diagnostic test was CBC, ordered for 3,944,990
women (65.6%) with threatened and non-complete spontaneous abortions. In
contrast, consulting physicians were utilized in only 492,434 cases of threatened
abortion, or 8.2% of patients. Lastly, 1,208,595 women with threatened and noncomplete spontaneous abortions (22.3%) received treatment for pain.

Table 2. Baseline characteristics and diagnostic procedures in a cohort of
5,882,623 threatened abortions and early pregnancy lossesA in the US

Age (years)
Mean
Race / Ethnicity

26.5
# threatened abortionsA (%)

White

2,493,636 (42.4%)

Black or African American

1,616,113 (27.5%)

Latina

1,015,221 (17.3%)

OtherB

334,608 (5.7%)

Blank / Missing

423,045 (7.2%)

Insurance Type
Private
Medicare
Medicaid / SCHIP
No charge / Charity
Self-Pay

2,020,767 (34.4%)
64,408 (1.1%)
2,013,142 (34.2%)
74461 (1.3%)
1,270,256 (21.6%)

Other

140,356 (2.4%)

Blank / Missing

299,233 (5.1%)
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Table 2. Baseline characteristics and diagnostic procedures in a cohort of
5,882,623 threatened abortions and early pregnancy losses in the USA
Hospital geographic region
Northeast

922,925 (15.7%)

Midwest

1,257,719 (21.4%)

South

2,439,501 (41.5%)

West

1,262,478 (21.5%)

Metropolitan status
MSA (Metropolitan Statistical Area)

649,858 (11.0%)

Non-MSA (includes micropolitan
5,232,765 (89.0%)
statistical areas)
Hospital ownership
Voluntary non-profit

4,079,210 (69.3%)

Government, non-Federal

938,616 (16.0%)

Proprietary

864,797 (14.7%)

Diagnostic Procedures
Ultrasound

2,910,112 (49.5%)

Pregnancy test

2,568,088 (43.7%)

CBC

3,868,366 (65.8%)

OB/GYN consult called

492,434 (8.4%)

Pain management
Received treatment for pain

1185,824 (20.2%)
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Table 2. Baseline characteristics and diagnostic procedures in a cohort of
5,882,623 threatened abortions and early pregnancy losses in the USA
Disposition
Admit to hospital

608,090 (10.3%)

Discharge to home

5,274,533 (89.7%)

Blank / Missing

19,904 (0.0%)

Management
Treated (surgical or medical)
Expectant

74,775 (1.3%)
5,807,848 (98.7%)

N= 5,882,623
A

Includes threatened abortions, spontaneous abortions except complete abortions,

and hemorrhage in pregnancy
B

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race

recorded

The effect of age, race/ethnicity, and socioeconomic characteristics on
dispositions and management of threatened and non-complete spontaneous
abortions as estimated by logistic regression are described in Table 3.

19

Table 3. Disposition of threatened abortions and early pregnancy losses in the USA,B
Disposition
Variable

Admit
n

Age (years)
Mean
Race / Ethnicity

Discharge
%

27.0

n

%
26.5

Adj
OR

(95% CI)

P-val

1.03

(1.03-1.03)

<0.001

White

257,873 10% 2,235,763 90%

1.00

Ref

Black

209,870 13% 1,406,243 87%

0.83

(0.83-0.84)

<0.001

Latina

69,823

7%

945,398 93%

0.00

(0.00-6.25e68)

0.83

OtherC

51,913 16%

282,695 84%

2.14

(2.11-2.17)

<0.001

18,611

404,434

1.00

Ref

61,871 96%

0.00

(0.00-5.06e168)

0.93

279,652 14% 1,733,490 86%

1.23

(1.22-1.24)

<0.001

73,438 99%

0.00

(0.00-1.41e217)

0.94

Blank
Insurance Type
Private
Medicare
Medicaid /
SCHIP
No charge /
Charity

207,284 10% 1,813,483 90%
2,537

1,023

4%

1%

Self-Pay

92,205

7% 1,178,051 93%

1.04

(1.03-1.05)

<0.001

Other

11,883

8%

0.00

(0.00-3.37e182)

0.93

Missing data
Hospital region

13,506

128,473 92%
285,727 95%

Northeast

164,960 18%

Midwest

159,244 13% 1,098,475 87%

South

197,058

8% 2,242,443 92%

West

86,828

7% 1,175,650 93%

757,965 82%

1.00
0.66
0.44
0.35

Ref
(0.66-0.67)

<0.001

(0.43-0.44)

<0.001

(0.35-0.35)

<0.001
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Table 3. Disposition of threatened abortions and early pregnancy losses in the USA,B
Disposition
Variable

Admit

Discharge

n

%

47,906

7%

n

%

Adj
OR

(95% CI)

1.00

Ref

P-val

Metropolitan status
Non-MSA

601,952 93%

MSA
560,184 11% 4,672,581 89%
Hospital ownership
Voluntary

428,407 11% 3,650,803 89%

Government

124,430 13%

Proprietary
A

55,253

6%

814,186 87%
809,544 94%

1.61

1.00
1.30
0.75

(1.59-1.62)

<0.001

Ref
(1.29-1.31)

<0.001

(0.75-0.76)

<0.001

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded

In assessing the effect of patient age on disposition, the odds of admission
increased incrementally by 3% for every 1-year increase in age (OR 1.03, 95%
CI 1.029-1.030). When evaluating the effect of race/ethnicity on disposition, black
women with threatened and spontaneous abortion were less likely to be admitted
compared to white women (0.83, 95% CI 0.83-0.84). Other women of color,
however, were nearly twice as likely to be admitted (OR 2.14, 95% CI 2.11-2.17),
though note that Latina ethnicity was not a significant variable affecting
disposition.
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Likewise, women with Medicaid / SCHIP (OR 1.23, 95% CI 1.22-1.24)
were also more likely to be admitted compared to privately-insured women.
Hospitals in every geographical region, including the Midwest (OR 0.66, 95% CI
0.66-0.67), South (OR 0.44, 95% CI 0.43-0.44), and West (OR 0.35, 95% CI
0.647-0.353), were less likely to admit for threatened and spontaneous abortion
compared to hospitals in the Northeast. Compared with hospitals in nonmetropolitan areas, metropolitan hospitals were more likely to admit women with
threatened abortion (OR 1.61, 95% CI 1.59-1.62). Lastly, government-owned
hospitals were more likely to admit patients (OR 1.30, 95% CI 1.29-1.31), while
proprietary hospitals were less likely to admit (OR 0.75, 95% CI 0.75-0.76)
compared to voluntary, non-profit hospitals.
The other major outcome assessed was the method of managing
threatened and non-complete spontaneous abortion, as affected by
socioeconomic factors (Table 4).
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Table 4. Management of all threatened abortions and early pregnancy losses in the USA,B
Management
Variable

Expectant
n

Active
%

n

Adj

(95% CI)

P-val

0.99

(0.99-0.99)

<0.001

1%

1.00

Ref

2%

4.37

(4.25-4.50)

<0.001

%

OR

Age (years)
Mean

26.5

27.4

Race / Ethnicity

White

2,531,160

99%

Black

1,642,011

98%

Latina

1,022,590

99%

5,367

1%

0.84

(0.80-0.89)

<0.001

OtherC

330,598

97%

10,434

3%

8.32

(8.06-8.59)

<0.001

Blank

415,152

19,845

32,738

7,893

Insurance Type

Private

1,995,112

98%

42,133

2%

1.00

Ref

62,087

96%

2,321

4%

0.00

(0.00-1.31e151)

2,068,567

100%

8,537

0%

0.11

(0.11-0.13)

66,759

90%

7,702

10%

0.00

(0.00-9.63e217)

1,298,069

99%

15,555

1%

3.73

(3.62-3.85)

Other

142,314

100%

0%

0.00

(0.00-6.29e172)

Missing data

308,603

Medicare

0.93

Medicaid /
SCHIP

<0.001

No charge /
Charity

Self-Pay

-

29

0.95

<0.001

0.94
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Table 4. Management of all threatened abortions and early pregnancy loss in the USA,B
Management
Variable

Expectant
n

Active
%

(95% CI)

%

Adj
OR

39,467 4%

1.00

Ref

0%

0.00

(0.00e6.22e19)

n

P-val

Hospital region

Northeast

899,804

96%

-

Midwest

1,288,168 100%

0.58

South

2,463,534

99%

29,948 1%

0.26

(0.25-0.26)

<0.001

West

1,290,005

99%

6,862 1%

0.13

(0.12-0.13)

<0.001

0%

1.00

Ref

Metropolitan status

Non-MSA

MSA

657,444 100%

-

5,284,067

99%

76,277 1%

1.61

(1.59-1.62)

0.71

4,117,092

99%

57,303 1%

1.00

Ref

Government

955,455

99%

6,057 1%

0.56

(0.55-0.58)

<0.001

Proprietary

868,964

99%

12,917 1%

1.64

(1.60-1.68)

<0.001

Hospital ownership

Voluntary

A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded
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Regardless of admission or discharge, the chances of active management
(receiving medication or surgery instead of expectant management) decreased
1% for every year that age increased (OR 0.99, 95% CI 0.992-0.994). Nonwhite
women were much more likely to undergo active management, including black
patients (OR 4.37, 95% CI 4.25-4.50) and other women of color (OR 8.32, 95%
CI 8.06-8.59). Interestingly, Latina women were less likely to receive active
management (OR 0.84, 95% CI 0.80-0.89). Insurance status was a significant
predictor: women paying out of pocket were more likely to undergo active
management (OR 3.73, 95% CI 3.62-3.85). However, Medicaid/SCHIP patients
were much less likely to receive active management (OR 0.11, 95% CI 0.110.13). Hospital geographic location also affected the odds of active
management, as hospitals located outside of the Northeast were less likely to
manage threatened and non-complete spontaneous abortions actively (South,
OR 0.26, 95% CI 0.25-0.26; West, OR 0.13, 95% CI 0.12-0.13). Government
hospitals were 0.56 times as likely to actively manage threatened and
spontaneous abortions (95% CI 0.55-0.58) compared to voluntary, for-profit
centers. However, proprietary hospitals were 1.56 times as likely to manage
patients actively (95% CI 1.60-1.68).
Besides assessing the effects of socioeconomic variables and hospital
characteristics on disposition and treatment of threatened and non-complete
spontaneous abortion, the present study also evaluated the effect of these
variables on diagnostic procedures (Table 5a-d). These included receipt of
ultrasound, pregnancy test, complete blood count, and evaluation by consulting
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physician, which was assumed to be an OB/GYN. Within each individual
diagnostic test, significant differences indeed existed with respect to patient race
and insurance, and hospital geographic region, metropolitan status, and
ownership. However, no consistent demographic trends were found when
evaluated across all four diagnostic procedures.

Table 5a. Ultrasound use in the emergency management of threatened
abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

26.6

1.01

(1.01-1.01)

<0.001

1,256,139 49.2%

1.00

Ref

Black

801,601 47.9%

1.66

(1.65-1.67)

<0.001

Latina

558,476 54.3%

1.49

(1.48-1.51)

<0.001

OtherC

142,301 41.7%

0.47

(0.46-0.47)

<0.001

Blank / Missing

191,293

1,073,261 52.7%

1.00

Ref

48,820 75.8%

6.55

(6.35-6.76)

<0.001

946,537 45.6%

0.77

(0.76-0.77)

<0.001

Age (years)
Mean
Race / Ethnicity

White

Insurance Type

Private

Medicare
Medicaid /
SCHIP
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Table 5a. Ultrasound use in the emergency management of threatened
abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

No charge /
Charity

Self-Pay

Other

Blank / Missing

50,676 68.1%

1.24

(1.20-1.27)

<0.001

615,138

46.8%

1.20

(1.19-1.21)

<0.001

53,274

37.4%

0.89

(0.87-0.91)

<0.001

162,104

Hospital region

Northeast

422,642

45.0%

1.00

Midwest

650,171

50.5%

1.42

(1.42-1.41)

<0.001

1,154,623

46.3%

1.17

(1.17-1.18)

<0.001

722,374

55.7%

1.63

(1.62-1.64)

<0.001

206,505

31.4%

1.00

2,743,305

51.2%

2.02

2,141,899

51.3%

1.00

Ref

Government

362,576

37.7%

0.57

(0.568-0.574)

<0.001

Proprietary

445,335

50.5%

0.87

(0.87-0.88)

<0.001

South

West

Ref

Metropolitan status

Non-MSA

MSA

Ref

(2.01-2.03)

<0.001

Hospital ownership

Voluntary
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A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded

Table 5b. Pregnancy test use in the emergency department management of
threatened abortions and early pregnancy lossA,B
n

Adj OR

(95% CI)

P-val

26.3

0.99

(0.99-0.99)

<0.001

1,130,646 44%

1.00

Ref

Black

765,931 46%

1.72

(1.71-1.73)

Latina

443,179 43%

1.47

OtherC

145,962 43%

1.28

Age (years)
Mean
Race / Ethnicity
White

Blank / Missing
Insurance Type
Private

%

(1.45-1.48)
(1.26-1.29)

<0.001
<0.001
<0.001

149,410

897,623 44%

1.00

Ref

Medicare
Medicaid /
SCHIP
No charge /
Charity

23,782 37%

0.69

(0.67-0.70)

<0.001

858,880 41%

1.36

(1.35-1.37)

<0.001

26,206 35%

0.20

(0.19-0.21)

<0.001

Self-Pay

637,437 49%

1.46

(1.45-1.47)

<0.001

57,920 41%

0.41

(0.39-0.42)

<0.001

Other
Blank / Missing

133,280
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Table 5b. Pregnancy test use in the emergency department
management of threatened abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

Hospital region
Northeast

319,350 34%

1.00

Ref

Midwest

622,368 48%

2.04

(2.03-2.05)

<0.001

1,206,450 48%

2.01

(2.00-2.05)

<0.001

486,960 38%

1.15

(1.15-1.16)

<0.001

205,984 31%

1.00

Ref

2,429,144 45%

2.22

(2.20-2.23)

1,889,168 45%

1.00

Ref

Government

374,448 39%

0.74

(0.74-0.75)

<0.001

Proprietary

371,512 42%

0.84

(0.83-0.84)

<0.001

South

West
Metropolitan status

Non-MSA

MSA

<0.001

Hospital ownership

Voluntary

A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded
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Table 5c. CBC use in the emergency department management of
threatened abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

1.00

(1.00-1.00)

0.64

Age (years)
Mean

26.6

Race / Ethnicity

White

1,753,793

69%

1.00

Ref

Black

984,660

59%

0.39

(0.38-0.39)

<0.001

Latina

694,714

68%

0.85

(0.84-0.86)

<0.001

OtherC

199,944

59%

0.50

(0.50-0.51)

<0.001

Blank / Missing

311,879

1,354,775

67%

1.00

Ref

47,493

74%

1.99

(1.94-2.05)

1,292,976

62%

0.68

(0.67-0.68)

33,551

45%

0.48

(0.47-0.49)

922,316

70%

1.08

(1.07-1.09)

<0.001

75,719

53%

0.37

(0.36-0.38)

<0.001

Insurance Type

Private

Medicare
Medicaid /
SCHIP
No charge /
Charity

Self-Pay

Other

Blank / Missing

218,160

<0.001

<0.001

<0.001
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Table 5c. CBC use in the emergency department management of
threatened abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

Hospital region

Northeast

596,733 64%

1.00

Ref

Midwest

720,827 56%

0.68

(0.68-0.69)

<0.001

1,705,404 68%

1.16

(1.15-1.17)

<0.001

922,026 71%

1.12

(1.11-1.13)

<0.001

370,797 56%

1.00

Ref

3,574,193 67%

1.60

(1.60-1.61)

2,767,384 66%

1.00

Ref

Government

541,204 56%

0.57

(0.567-0.573)

<0.001

Proprietary

636,402 72%

1.18

(1.17-1.19)

<0.001

South

West
Metropolitan status

Non-MSA

MSA

<0.001

Hospital ownership

Voluntary

A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded
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Table 5d. OB/GYN consult use in the emergency department management of
threatened abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

1.05

(1.05-1.05)

<0.001

Age (years)
Mean

28.2

Race / Ethnicity
White

210,776

8%

1.00

Ref

Black

136,397

8%

0.81

(0.80-0.83)

<0.001

Latina

60,238

6%

0.53

(0.52-0.54)

<0.001

Other

53,947 16%

1.13

(1.12-1.15)

<0.001

Blank / Missing

31,076

8%

1.00

Ref

7,995 12%

1.63

(1.58-1.68)

6%

0.50

(0.49-0.50)

18,827 25%

0.00

(0.00-2.02e218)

9%

1.49

(1.47-1.51)

<0.001

Other

17,895 13%

0.00

(0.00-2.60e181)

0.93

Blank / Missing

27,655

1.00

Ref

Insurance Type
Private
Medicare
Medicaid /
SCHIP
No charge /
Charity
Self-Pay

170,580

131,007

118,475

<0.001

<0.001

0.94

Hospital region
Northeast

135,892 14%
64,801

5%

0.33

(0.32-0.33)

<0.001

South

193,239

8%

0.60

(0.60-0.61)

<0.001

West

98,502

8%

0.66

(0.65-0.67)

<0.001

Midwest
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Table 5d. OB/GYN consult use in the emergency department management of
threatened abortions and early pregnancy lossA,B
n

%

Adj OR

(95% CI)

P-val

126,688

19%

1.00

Ref

1,081,907

20%

0.43

(0.43-0.43)

372,155

9%

1.00

Ref

Government

74,317

8%

0.88

(0.87-0.89)

<0.001

Proprietary

45,962

5%

0.61

(0.61-0.62)

<0.001

Metropolitan status
Non-MSA
MSA

<0.001

Hospital ownership
Voluntary

A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded

Our study also identified important differences in pain management based on
socioeconomic and demographic factors (Table 6). Compared to white women,
every other race was less likely to be treated for pain: Latina women were the
least likely (OR 0.29, 95% CI 0.28-0.29), followed by black women (OR 0.46,
95% CI 0.46-0.47), and “Other” women of color (OR 0.57, 95% CI 0.57-0.58).
Perhaps counterintuitively, women with Medicaid / SCHIP insurance were 13%
more likely to receive pain medication compared to privately-insured women (OR
1.13, 95% CI 1.12-1.13). Women with all other types of insurance, however, were
less likely to receive pain medication; patients receiving free or charity care were
0.21 times as likely to be treated for pain compared to privately-insured patients
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(95% CI 0.20-0.23). Medicare-insured patients were nearly half as likely to
receive pain treatment (OR 0.46, 95% CI 0.44-0.47), and patients paying out of
pocket were 0.67 times as likely compared to privately-insured patients (OR 0.67,
95% CI 0.67-068). Hospitals located in all geographic regions were more likely to
prescribe pain medications compared to hospitals in the Northeast, including
those in the Midwest (OR 1.33, 95% CI 1.32-1.34), South (OR 1.77, 95% CI
1.76-1.78), and West (OR 2.10, 95% CI 2.08-2.11). Metropolitan hospitals were
23% more likely than non-metropolitan hospitals to treat pain in the ED (OR 1.23,
95% CI 1.23-1.24). Both government-owned hospitals (OR 1.23, 95% CI 1.221.24) and proprietary hospitals (OR 1.16, 95% CI 1.16-1.17) were more likely to
treat pain compared to voluntary non-profit hospitals.

Table 6. Treatment of pain in threatened abortions and early
pregnancy lossA.B
n

%

Adj OR

(95% CI)

P-val

Age (years)
Mean
Race / Ethnicity

26.8

1.00

White

607,942 36%

1.00

Black

317,792 31%

0.46

(0.46-0.47) <0.001

Latina

160,798 47%

0.29

(0.28-0.29) <0.001

OtherC

59,580 14%

0.57

(0.57-0.58) <0.001

Blank / Missing
Insurance Type
Private
Medicare

(1.01-1.01) <0.001

Ref

62,483

398,977 20%
4,700

7%

1.00
0.46

Ref
(0.44-0.47) <0.001

34

Medicaid /
SCHIP

482,281 23%

1.13

(1.12-1.13) <0.001

14,179 19%

0.21

(0.20-0.23) <0.001

223,713 17%

0.67

(0.67-0.68) <0.001

Other

50,653 36%

2.32

(2.26-2.37) <0.001

Blank / Missing

34,092

No charge /
Charity
Self-Pay

<0.001

Hospital region
Northeast

125,177 13%

1.00

Ref

Midwest

227,663 18%

1.33

(1.32-1.34)

<0.001

South

539,418 22%

1.77

(1.76-1.78)

<0.001

West

316,337 24%

2.10

(2.08-2.11)

<0.001

126,688 19%

1.00

Ref

20%

1.23

(1.23-1.24)

Voluntary

779,699 19%

1.00

Ref

Government

218,777 23%

1.23

(1.22-1.24)

<0.001

Proprietary

210,119 24%

1.16

(1.16-1.17)

<0.001

Metropolitan status
Non-MSA
MSA

1,081,907

<0.001

Hospital ownership

A

Includes threatened abortions, spontaneous abortions except complete abortions, and

hemorrhage in pregnancy
B

Unless otherwise noted, values are given as a weighted number and % of threatened

abortions within each demographic segment, adjusgted for demographic factors
C

Includes Asian, Native Hawaiian, Native Alaskan, Native American, 1+ race recorded

Discussion
The definition of “health disparity” varies across multiple institutions. The
World Health Organization (WHO) uses the broadest definition, citing “disparities”
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as “differences in health which are not only unnecessary and avoidable but, in
addition, are considered unfair and unjust [35].” The Agency for Healthcare
Research and Quality (AHRQ) cites disparities where any statistically significant
differences among populations are found, differing from the reference group by at
least 10 percent [36]. Here we use both of these definitions when referencing
“healthcare disparities”. Given the limited data on clinical picture and patient
preference within the NHAMCS, our use of “healthcare disparities” does not align
with the Institute of Medicine (IOM) definition: “racial or ethnic differences in the
quality of health-care that are not due to access-related factors or clinical needs,
preferences, and appropriateness of intervention” [46].
Racial and socioeconomic disparities are known to exist within obstetrics
and gynecology. These span from maternal morbidities [47] and delivery
complications [48] to poor obstetric outcomes, where uninsured and minority
women are more likely to experience preterm births, low birth weights, and
intrauterine fetal loss [49-54]. Similar racial/ethnic and socioeconomic disparities
have also been identified in spontaneous abortion. Compared to white women,
black women may be twice as likely to experience miscarriage [26]. Nonwhite
women may be four times as likely to die from spontaneous abortion [22].
Disparate pregnancy outcomes have been attributed to differences in healthcare
access [27, 28] and healthcare-seeking behaviors [30-32] among marginalized
populations, or even provider bias [46]. However, recent studies have also
identified racially-based differences in the management of obstetrics problems –
such as the medical and surgical treatment of ectopic pregnancy [27, 55].
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Similarly, our study sought to identify disparities in management of incomplete
and delayed spontaneous abortion, collectively referenced here as non-complete
spontaneous abortion here, as well as threatened abortion – which can lead to
miscarriage in 50% of cases [2].
We found that racial and socioeconomic differences indeed exist, even
among different minority groups. Firstly, several minority and historicallyvulnerable groups were more likely to be admitted for threatened abortion,
compared to white and privately-insured women. These included “Other” women
of color (Asian, Native American, Native Hawaiian, Native Alaskan, and mixed
race), uninsured women, and Medicaid-insured women. Regardless of
disposition, active treatment was more common among uninsured women, black
women, and “Other” women of color, compared to white and privately-insured
women. Note that although these odds ratios were statistically significant, they do
reflect only a small subset of our cohort. Expectant management was by far the
most preferred treatment modality in our cohort, which is reasonable given that
diagnoses ranged from early pregnancy hemorrhage to spontaneous abortion.
The decision to admit or actively treat threatened and spontaneous
abortion is multifactorial. It may be influenced by clinical complexity, patient
preference, or decisions at provider level – introducing potential subjectivity or
biases. Our findings are consistent with previous studies, which have also
suggested that providers opt to “actively” treat nonwhite women and women at
risk for poor obstetrics outcomes. C-sections, for instance, are an “active” form of
managing pregnancy that is performed at a higher rate among nonwhite women
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[37]. Asian and “Other” women of color are more likely to receive surgery instead
of nonsurgical treatment for ectopic pregnancy, compared to white women [27].
Low-income, nonprivately insured, black, and Latina women are less likely to
undergo the less invasive surgery, laparoscopic hysterectomy, versus open
hysterectomy compared to white women [38]. Surgical sterilization is used in
nearly one fifth of sexually active black and Latina women desiring contraception,
compared to only 16% of white women, who are more likely to use oral
contraceptives [56]. Surgical abortions, instead of medical, may be preferentially
recommended to low income, non-English-speaking women seeking elective
abortion [57]. Note that in our study, both surgery and misoprostol are considered
“active” ways to manage spontaneous abortion. Elective abortions, however,
cannot be treated expectantly. Therefore, in receiving counsel to choose surgical
over medical management, these populations are offered the more “active” of the
two treatments options.
In choosing a mode of management, providers’ concerns range from poor
adherence, loss to follow-up, miscommunication, or low medical literacy.
Expectant management, for instance, often results in follow-up visits, as nearly
70% of women request surgery by two weeks post-diagnosis [45]. In the setting
of incomplete abortion, expectant management has also been found to result in
more frequent unscheduled visits, hospital admissions, and need for curettage
compared to medically induced abortion, according to another, single-site study
[58]. Providers may view admission or active management as a definitive way to
preempt adverse maternal or neonatal outcomes in at-risk populations.
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This line of reasoning for candidate selection has been studied and even
recommended in other obstetrics outcomes. Jasper et al (2010) and DuenasGarcia et al (2013) suggest that patient compliance should be considered when
choosing between methotrexate and surgery, the more active of the two
treatment modalities for ectopic pregnancy. Both studies found low rates of
methotrexate compliance in inner-city patients presenting with ectopic pregnancy
[55, 59]. Specifically, compared with treatment success rates of 85% in
appropriately selected subjects, only 19.7% patients at Albert Einstein Medical
Center from 2004-2007 complied with a single-dose regimen. Even after
intensive efforts to encourage follow-up including multiple phone calls and
reminders, less than half of women were followed to resolution [55]. DuenasGarcia et al (2013) found similar rates (10.1%) of noncompliance in a Bronxbased study of predominantly black and Latina women, where noncompliance
was defined as missing three or more visits and requiring recall by telephone or
telegram [59]. Both studies suggest that providers should, in fact, consider
compliance in selecting appropriate candidates for medical treatment in ectopic
pregnancy. The implication is that women who are not candidates would instead
be recommended for surgical treatment, reinforcing the practice of using active
management to mitigate risk for adverse outcomes.
Although considerations of compliance often affect treatment decisions,
limited studies have examined compliance in the setting of treatment for
spontaneous abortion. Among a predominantly white group of 100 women [58]
and 550 patients in Sweden [11], compliance was found to be high, with very few
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women opting to undergo surgery. However, these studies did not examine the
rates of adherence to follow-up appointments. They were also performed using a
small sample size, and provided limited information regarding the racial/ethnic or
socioeconomic composition of the study populations. Future studies might
compare treatment modalities and their rates of compliance, complications, and
other outcomes within at-risk populations.
Our study also identified several unexpected relationships between
socioeconomic variables and threatened abortion management. Unlike other
minority groups, black women were less likely to be admitted compared to white
women. The disparity may be even greater than reflected here when including
patients who were admitted directly to the hospital from their outpatient providers.
These patients are likely comprised of mostly white patients; black patients tend
to seek care in outpatient settings less often, instead obtaining care from
emergency department and inpatient settings [60].
In contrast to black women, “Other” women of color actually had double
the chance of admission compared to whites. With these findings in mind,
underrepresented groups might be expected to exhibit similar patterns in
management. One possible explanation is patient preference. Many immigrant,
minority, low-income, and other marginalized groups have suffered severe
injustices within obstetrics [61, 62]. However, black patients may experience a
disparate degree of distrust in the medical system [63], resultantly affecting their
preferences in management. Additionally, “Other” women of color may face the
added risk factor of more significant language barriers, which may contribute to
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increased likelihood of admission. Asian-language speakers in Hawaii, for
instance, experience higher rates of obstetric complications – an effect that has
been mitigated in other countries with the use of interpreters [64, 65]. To avoid
complications arising from miscommunication and loss to follow-up [46],
providers may attempt to admit and actively manage these patients. Note,
however, that stereotyped beliefs about women of color may also cause
providers to perceive or assume presence of a language barrier [46]. The
presumption alone of a language barrier may also influence provider-based
decisions on treatment modality.
This explanation, however, does not account for our findings regarding
Latina patients. Latina women were the only minority group less likely to
undergo active treatment compared to white women, which may seem
counterintuitive. Like other minorities and marginalized populations, Latina
women face adverse social risk factors: delayed access to prenatal care,
language barriers, and lower socioeconomic status. However, Latina women
actually experience better birth outcomes compared to blacks – an
epidemiological finding documented as the Hispanic Paradox [32, 66-68]. With
such notable discrepancies in outcomes, it seems possible that differences in
management contribute in some capacity.
Moreover, Latinas have also demonstrated lower rates of active
management in pregnancy. Rates of CS from 1996-2006 increased for every
race, but increased the least for Latinas. For over two decades, Latina women
persistently have had one of the lowest CS rates among multiple racial/ethnic
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groups [32]. A nine-year, nationwide study of ectopic pregnancy among 35,000
women found that Latinas were the only racial/ethnic group more likely to receive
nonsurgical versus surgical management compared to white women [27];
however, results for Latina and black women may not have been statistically
significant (p-values > 0.05). Nevertheless, our explanations ultimately remain
speculative. Many factors contribute to the process of medical decision-making,
which renders our findings difficult to explain. Note, however, that one single-site
study found that Latinas discharged from obstetrical services were 3.6 times as
likely to report a lack of respect for their preferences, when compared to whites
(OR 3.6; CI 1.6-8.2) [69]. In this context, one must consider that discrepancies in
the obstetric management of Latina women may not, in fact, be entirely patientdriven.
Race/ethnicity or insurance provider was not associated with any
consistent patterns of usage across multiple diagnostic tests, which is perhaps a
more meaningful way to identify demographically-based discrepancies in workup. Geographic location of emergency department, however, was another
significant variable that influenced disposition, management, use of OB/GYN
consult, and pain management. Specifically, we found that hospitals located in
the Northeast region were more likely to admit, actively manage, and utilize a
consulting physician for threatened abortion, compared to EDs in all other US
regions. In general, rates of inpatient admission from the ED are higher in the
Northeast compared to all other regions [70]. More specific studies on ED
admission and discharge for obstetrics-related diagnoses were highly limited;

42

however, an older study on acute and unspecified pelvic inflammatory disease
from 1985-2001 found that Southern outpatient departments actually had the
highest rates of hospitalization, followed closely by Northeastern and Midwestern
hospitals. Our finding that Northeastern hospitals demonstrate higher rates of
admission or active management is complicated to interpret without additional
context. For instance, regional variability may exist with respect to availability of
inpatient beds, accessibility to consulting physicians, or even patient
characteristics like severity or gestational age at presentation – which are
associated with race/ethnicity and socioeconomic status.
Lastly, our study found that all groups of nonwhite women, Medicaidinsured women, and uninsured women were all far less likely to receive pain
medication compared to white and privately-insured women. The undertreatment
of painful conditions, or oligoanalgesia, in the emergency department and other
settings has been well-documented since the late 1980s [71]. Demographic risk
factors for oligoanalgesia are also widely known, including age, race/ethnicity,
socioceconomic status, and geographic location of the hospital [72]. These
disparities exist across various types of pain and conditions. An NHAMCS study
on 175,351 ED visits for acute abdominal pain over five years found that black
patients and patients of other races/ethnicities were 17-30% less likely to receive
narcotic analgesia (p<0.05) and 22-30% less likely to receive analgesia (OR
(95% CI)=0.78 (0.67–0.90); 0.70 (0.56–0.88)) compared to non-Hispanic white
patients with similar complaints [73]. Todd et al (1993) found that Hispanics with
long-bone fractures were twice as likely as comparably-injured white patients to
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receive no pain medication [74]; blacks with isolated long-bone fractures were
also less likely to receive analgesics compared to their white counterparts [75].
Blacks with migraine headaches and back pain may receive less intensive
diagnostic work-up [76] and less opioid treatment [77]. Regarding post-surgical
pain, another study on post-surgical narcotic use found that whites received
higher prescriptions of morphine compared to Hispanics and Asians, even after
controlling for age, gender, previous narcotic use, and pain site [78]; the same
study found that blacks were prescribed a higher opioid dose than Hispanics and
Asians.
Oligoanalgesia has also been studied specifically in obstetrics. One
single-site study of 3,000 women found that when English was not the patient’s
preferred language, obstetrics patients were 0.82 as likely to receive neuraxial
labor analgesia (OR 0.82, 95% CI 0.67-0.99) [79]. Multiple other studies have
also shown racial disparities in epidural analgesia use. For instance, even after
adjusting for insurance status, provider effect, and clinical differences, one
retrospective cohort study of 80,000 patients showed that black and Latina were
less likely to receive epidural analgesia compared to white patients [80]. Similar
findings were demonstrated in another study of nearly 30,000 Medicaid-insured
obstetrics patients, where rates of epidural analgesia use were lower in black
(49.5%), Hispanic (35.3%), and Asian (48.1%) women compared to white, nonHispanic women (59.6%, p<0.001) [81]. This persisted even after adjusting for
age, geographical location, and access to anesthesiologists. Educational level
has also been identified as an influential factor in receiving labor analgesia,
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where graduation from high school was strongly associated with requesting
epidural [82].
A variety of factors may contribute to these disparities in pain treatment,
within obstetric as well as other conditions. Treatment of pain in the ED also
involves multi-step communication between several parties. The patient must
perceive and express pain, sometimes through a family member or other
advocate, to the provider, which may include nurse and physician. While several
studies have not identified differences in the perception of pain across
races/ethnicities [83, 84], racial/ethnic or cultural variations in the expression of
pain may indeed exist [83]. On the provider’s end, whether or not the provider
perceives an exaggeration of pain has been found to differ based on the patient’s
ethnicity, ultimately affecting the achievement of pain relief [85].
Additionally, differences in patients’ degree of knowledge about pain
treatment options or health literacy may affect pain treatment, as suggested by
the association between educational level and requesting epidural in labor
epidural [82]. Note, however, that one study found disparities in prescription for
opioid pain treatment despite similar subjective pain scores, expectations for pain
relief, and knowledge of PCA [78]. Fear of side effects of treatment or varying
cultural beliefs regarding pain and suffering may also influence pain treatment
[86]. Patients may also experience extrinsic pressure from family or healthcare
providers [46], though interestingly, one small study found that minorities were
actually more likely to feel pressured by their providers to accept analgesia in
labor [87]. Language barriers may also contribute [79], although other studies
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have found that ethnicity influences pain treatment regardless of language [74].
Other influential factors on pain treatment may include true drug-seeking among
patients, the perception of drug-seeking behavior in a patient, inadequate
provider training, or racial stereotyping.
Limitations:
Several important limitations affected our study. Firstly, this was a
retrospective study using aggregate data from various emergency department
settings across the country. This excludes data on management after hospital
admission or within private clinics, where threatened abortions can be admitted
directly to the hospital or simply treated on-site. Additionally, our study collapsed
Asians, Native Alaskans, Native Hawaiians, and mixed race women into one
group due to small sample size. We appreciate the heterogeneity of women that
comprise this group, which poses limitations to any conclusions drawn after
grouping “Other” women of color collectively.
In using administrative data, our study was limited by unknown errors in
the input or documentation of race, income, insurance providers, procedures, or
medications. Without data from individual charts, the study is also unable to
capture physician or patient preferences in the medical decision-making process.
Of note, “admission to the OR” was not a recordable disposition from 2002-2004.
As this disposition was used to identify surgical treatment, the proportion of
cases managed “actively” to “expectantly” may be even greater. Moreover, we
cannot be certain of the extent to which differences in management translate to
clinical differences, as patient outcomes were not examined in this study.
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Importantly, our findings could not incorporate considerations of
gestational age at presentation, a data point not recorded in NHAMCS.
Management decisions may vary with gestational age: a second-term
hemorrhage is more likely to warrant admission or surgery than minor, first-term
bleeding. If a racially-based disparity existed with respect to gestational age at
presentation, our study would have only captured the resulting disparity in
treatment. Here we find that black women are more likely to be discharged;
perhaps they simply experience a disproportionately high occurrence of minor,
early-term vaginal bleeding. However, given that black women tend to delay
seeking prenatal care [27, 28], it seems more likely they would present at a later
gestational age compared to white women. Of note, ACOG guidelines
recommend limiting expectant management to presentation within the first
trimester [9]. Furthermore, the risk of spontaneous abortion-related death
increases for women presenting at later gestational age [22].
Conclusion:
In spite of these limitations, our study also has a number of strengths.
Firstly, it is a population-based sample reflective of cases nationwide. Secondly,
the dataset is extremely large, including over five million (weighted) cases of
threatened abortion, incomplete abortion, delayed abortion, and other
hemorrhage in pregnancy over a nine-year period (2002-2010). Together, these
characteristics allowed for appropriate generalization when identifying
demographically-based disparities in management among women in the United
States. While individual chart review may have added more granular detail to our
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findings, the relationships identified here may not have been elicited in a smaller
or single-site study. Finally, we used data aggregated in the NHAMCS,
administered by the Centers for Disease Control and Prevention, National Center
for Health Statistics. Specially trained interviewers collect data provided by the
physician rather than patients, providing a clinical base. The NHAMCS is also the
largest extant national emergency department database, further strengthening
our study’s findings.
The demographically-based disparities in management identified in our
study echo other documented differences within reproductive health. The etiology
of these disparities is complex, but may reveal persistent barriers to
communication and healthcare access. If providers are indeed using admission
or active management to mitigate true or perceived risks in a population, perhaps
additional resources should be directed towards improving patients’ social
support, follow-up, or adherence. Providers may also seek to better understand
their own stereotypes or preconceptions of patient risk, and work towards
strengthening communication and shared decision-making.
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